99 related articles for article (PubMed ID: 7609334)
1. [Effects of beraprost sodium (a PGI2 derivative) on chronic hypoxic pulmonary hypertension in the rat].
Saito M; Tatsumi K; Kasahara Y; Tani T; Kuriyama T
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 May; 33(5):497-504. PubMed ID: 7609334
[TBL] [Abstract][Full Text] [Related]
2. Effects of inhaled prostacyclin analogue on chronic hypoxic pulmonary hypertension.
Abe Y; Tatsumi K; Sugito K; Ikeda Y; Kimura H; Kuriyama T
J Cardiovasc Pharmacol; 2001 Mar; 37(3):239-51. PubMed ID: 11243414
[TBL] [Abstract][Full Text] [Related]
3. [Effects of thromboxane A2 on chronic hypoxic pulmonary hypertension in the rat].
Saito M; Tatsumi K; Kasahara Y; Sugito K; Igari H; Tani T; Kuriyama T
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jan; 34(1):37-44. PubMed ID: 8717289
[TBL] [Abstract][Full Text] [Related]
4. A long-acting and highly selective prostacyclin receptor agonist prodrug, 2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide (NS-304), ameliorates rat pulmonary hypertension with unique relaxant responses of its active form, {4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}acetic acid (MRE-269), on rat pulmonary artery.
Kuwano K; Hashino A; Noda K; Kosugi K; Kuwabara K
J Pharmacol Exp Ther; 2008 Sep; 326(3):691-9. PubMed ID: 18552131
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil and beraprost combination therapy in patients with pulmonary hypertension undergoing valvular heart surgery.
Kim SY; Shim JK; Shim YH; Hong SW; Choi KH; Kwak YL
J Heart Valve Dis; 2010 May; 19(3):333-40. PubMed ID: 20583396
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of the single isomer, esuberaprost (beraprost-314d) on pulmonary vascular tone, IP receptors and human smooth muscle proliferation in pulmonary hypertension.
Shen L; Patel JA; Norel X; Moledina S; Whittle BJ; von Kessler K; Sista P; Clapp LH
Biochem Pharmacol; 2019 Aug; 166():242-252. PubMed ID: 31158340
[TBL] [Abstract][Full Text] [Related]
7. Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.
Melian EB; Goa KL
Drugs; 2002; 62(1):107-33. PubMed ID: 11790158
[TBL] [Abstract][Full Text] [Related]
8. Perfusion lung scan as a prognostic indicator of response to beraprost sodium in idiopathic pulmonary arterial hypertension.
Park SY; Moon DH; Park YB; Na JO; Whang HK; Lim BS; Lee SD
Pulm Pharmacol Ther; 2006; 19(4):264-71. PubMed ID: 16139536
[TBL] [Abstract][Full Text] [Related]
9. Beraprost sodium, a stable prostacyclin analogue, elicits dilation of isolated porcine retinal arterioles: roles of eNOS and potassium channels.
Ono S; Nagaoka T; Omae T; Tanano I; Kamiya T; Otani S; Ishibazawa A; Yoshida A
Invest Ophthalmol Vis Sci; 2014 Jul; 55(9):5752-9. PubMed ID: 25082887
[TBL] [Abstract][Full Text] [Related]
10. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
[TBL] [Abstract][Full Text] [Related]
11. [Protective effects of beraprost plus simvastatin on monocrotaline-induced pulmonary arterial hypertension in rats].
Wang SH; Liu S; Yang JH; Wang ZZ; Li J; Hou WW
Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(22):1691-5. PubMed ID: 24124673
[TBL] [Abstract][Full Text] [Related]
12. Combined inhaled nitric oxide and inhaled prostacyclin during experimental chronic pulmonary hypertension.
Hill LL; Pearl RG
J Appl Physiol (1985); 1999 Apr; 86(4):1160-4. PubMed ID: 10194197
[TBL] [Abstract][Full Text] [Related]
13. Short-term hemodynamic effect of a new oral PGI2 analogue, beraprost, in primary and secondary pulmonary hypertension.
Saji T; Ozawa Y; Ishikita T; Matsuura H; Matsuo N
Am J Cardiol; 1996 Jul; 78(2):244-7. PubMed ID: 8712155
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of beraprost sodium, a stable prostacyclin analogue, in development of monocrotaline-induced pulmonary hypertension.
Miyata M; Ueno Y; Sekine H; Ito O; Sakuma F; Koike H; Nishio S; Nishimaki T; Kasukawa R
J Cardiovasc Pharmacol; 1996 Jan; 27(1):20-6. PubMed ID: 8656653
[TBL] [Abstract][Full Text] [Related]
15. A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats.
Itoh T; Nagaya N; Fujii T; Iwase T; Nakanishi N; Hamada K; Kangawa K; Kimura H
Am J Respir Crit Care Med; 2004 Jan; 169(1):34-8. PubMed ID: 14525801
[TBL] [Abstract][Full Text] [Related]
16. Additive effect of beraprost on pulmonary vasodilation by inhaled nitric oxide in children with pulmonary hypertension.
Ichida F; Uese K; Tsubata S; Hashimoto I; Hamamichi Y; Fukahara K; Murakami A; Miyawaki T
Am J Cardiol; 1997 Sep; 80(5):662-4. PubMed ID: 9295007
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary vasodilation with structurally altered pulmonary vessels and pulmonary hypertension.
Orton EC; Reeves JT; Stenmark KR
J Appl Physiol (1985); 1988 Dec; 65(6):2459-67. PubMed ID: 3063708
[TBL] [Abstract][Full Text] [Related]
18. Prostanoid therapy for pulmonary arterial hypertension.
Badesch DB; McLaughlin VV; Delcroix M; Vizza CD; Olschewski H; Sitbon O; Barst RJ
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
[TBL] [Abstract][Full Text] [Related]
19. [Systemic lupus erythematosus with pulmonary hypertension--normalization of pulmonary artery pressure by long-term administration of beraprost sodium].
Ubukata M; Motegi M; Sendo Y; Suzuki T
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1307-12. PubMed ID: 8583727
[TBL] [Abstract][Full Text] [Related]
20. Beneficial hemodynamic effects of oral prostacyclin (PGI2) analogue, beraprost sodium, on a patient with primary pulmonary hypertension--a case report.
Hashida H; Hamada M; Shigematsu Y; Ikeda S; Kuwahara T; Kawakami H; Hara Y; Kodama K; Kohara K; Hiwada K
Angiology; 1998 Feb; 49(2):161-4. PubMed ID: 9482517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
